Panax Ganoderma Saussurea Herbal Composition for Chronic Disease Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for chronic diseases such as hepatitis B and cancer are often associated with adverse side effects, viral resistance, complex administration methods, and high costs, lacking effective and well-tolerated natural compositions for symptom relief.
Innovation Solution
Compositions comprising extracts from plants of the genus Panax, fungi of the genus Ganoderma, and plants of the genus Saussurea, which are traditionally used in Chinese medicine, are combined to inhibit HBV antigen expression, inflammatory cytokine secretion, cancer cell proliferation, liver damage, and hepatoma formation, offering a potential adjuvant or neoadjuvant therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments (chemotherapy, radiation therapy, surgery) are used to treat chronic diseases, then disease symptoms are addressed, but adverse side effects increase and quality of life decreases
Solution Approach 1:
The patent combines multiple herbal extracts (Panax ginseng, Ganoderma lucidum, Saussurea involucrata) into a composite pharmaceutical composition. This composite approach leverages the synergistic effects of different natural compounds to achieve therapeutic benefits while reducing the toxicity associated with conventional single-agent treatments.
Solution Approach 2:
The patent employs natural, biodegradable herbal extracts instead of synthetic chemicals with long-term accumulation and persistent toxicity. These natural compounds are metabolized and eliminated by the body, reducing the burden of chronic toxicity and organ damage.
2Reliability
If conventional cancer treatments are used, then tumor growth is targeted, but healthy tissue is damaged and immune system components are reduced
Solution Approach 1:
The herbal composition targets cancer cells specifically through the selective toxicity of natural compounds. The active constituents in the extracts demonstrate preferential accumulation and action on malignant cells while sparing normal tissues, achieving local differentiation in treatment effect.
Solution Approach 2:
The patent uses herbal extracts as intermediary substances that mediate between the patient's immune system and cancer cells. These natural compounds modulate immune response and enhance the body's own anti-tumor mechanisms rather than directly attacking all rapidly dividing cells as conventional chemotherapy does.
3Reliability
If antiviral drugs are used to treat HBV, then viral infection is targeted, but viral resistance develops and treatment complexity increases
Solution Approach 1:
The multi-component herbal composition contains numerous different chemical compounds that can act on multiple viral targets and pathways simultaneously. This polypharmacological approach reduces the likelihood of resistance development compared to single-agent antiviral therapy, as the virus would need to develop multiple simultaneous resistance mechanisms.
Solution Approach 2:
The natural compounds in the herbal extracts may exhibit periodic or cyclical patterns of action on viral replication cycles, interfering with different stages of the viral life cycle. This multi-stage interference pattern makes it difficult for the virus to develop resistance through single-point mutations.
Data Source
AI summary
Compounds having unique properties are prepared from the herbal compositions described herein and comprise extracts derived from plants and fungi of the genera Panax, Ganoderma, and Saussurea. The compositions are useful in preventing, treating, relieving, and improving the quality-of-life of patients suffering from chronic diseases, such as liver diseases, cancer, cachexia, and immune system disorders.